Drug Development for Maternal Health Cannot Be Left to the Whims of the Market

ThePLoS Medicine Editors argue that the current business model of the pharmaceutical industry provides no incentives for the development of new treatments for maternal health, and that political will is needed to support new approaches.

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504051/
https://www.ncbi.nlm.nih.gov/pubmed/18578567
http://dx.doi.org/10.1371/journal.pmed.0050140
Descripción
Sumario:ThePLoS Medicine Editors argue that the current business model of the pharmaceutical industry provides no incentives for the development of new treatments for maternal health, and that political will is needed to support new approaches.

Ejemplares similares